This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Pentraxin Therapeutics Limited. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Vittorio Bellotti: Innovator in Amyloidosis Treatment
Introduction
Vittorio Bellotti is a notable inventor based in Pavia, Italy. He has made significant contributions to the field of medicine, particularly in the treatment of amyloidosis. His innovative work has led to the development of a unique compound that plays a crucial role in stabilizing transthyretin.
Latest Patents
Vittorio Bellotti holds a patent for a compound and its use in the treatment of amyloidosis. The patent describes compounds of formula (I) that are designed to stabilize the tetrameric form of transthyretin. This invention is pivotal for the treatment or prevention of amyloidosis, and it includes agents and medicaments that comprise such compounds.
Career Highlights
Vittorio Bellotti is associated with Pentraxin Therapeutics Limited, where he continues to advance his research and development efforts. His work has garnered attention in the scientific community, particularly for its potential impact on patients suffering from amyloidosis.
Collaborations
He has collaborated with esteemed colleagues such as Mark Brian Pepys and Steven Victor Ley. Their combined expertise has contributed to the advancement of research in this critical area of medicine.
Conclusion
Vittorio Bellotti's innovative contributions to the treatment of amyloidosis highlight his role as a leading inventor in the medical field. His work not only showcases his dedication to scientific advancement but also offers hope for improved treatments for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile